Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth factor expression in normal, benign, and malignant breast tissue.

M T Travers1, P J Barrett-Lee, U Berger

  • 1Ludwig Institute for Cancer Research, St George's Hospital Medical School, London.

British Medical Journal (Clinical Research Ed.)
|June 11, 1988
PubMed
Summary

This study found that transforming growth factor beta messenger RNA was more abundant in breast cancers than non-malignant tissue. Growth factors like transforming growth factor alpha and its receptor may play a role in hormone-independent breast cancer growth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer.

Breast cancer research and treatment·2011
Same author

Transabdominal bilateral adrenalectomy for metastatic breast carcinoma.

Annals of the Royal College of Surgeons of England·2009
Same author

Critical comment.

Annals of the Royal College of Surgeons of England·2009
Same author

Provision and acceptability of day case breast biopsy: an audit of current practice: Invited comment.

Annals of the Royal College of Surgeons of England·2009
Same author

Provision and acceptability of day case breast biopsy: an audit of current practice.

Annals of the Royal College of Surgeons of England·2009
Same author

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring.

British journal of cancer·2009

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Oncogenes can encode growth factors involved in tumor cell regulation.
  • Understanding endogenous synthesis of growth factors by tumor cells is crucial.
  • Breast cancer development may involve dysregulated growth factor signaling.

Purpose of the Study:

  • To investigate the endogenous synthesis of specific growth factors in breast tumor tissues.
  • To compare the expression levels of growth factor messenger RNA (mRNA) in malignant, non-malignant, and normal breast tissues.
  • To determine the potential role of growth factors in different subtypes of breast cancer, including hormone-dependent and independent types.

Main Methods:

  • Analysis of messenger RNA (mRNA) levels for transforming growth factor beta, transforming growth factor alpha, epidermal growth factor receptor, insulin-like growth factor II, and platelet-derived growth factor A and B chains.

Related Experiment Videos

  • Examination of biopsy specimens from 52 malignant breast tumors, 15 non-malignant breast tumors, and 4 normal breast tissue samples.
  • Correlation of growth factor mRNA expression with oestrogen receptor status in breast carcinomas.

    • Main Results:

    • Transforming growth factor beta mRNA was significantly more abundant in breast cancers (76%) compared to non-malignant tissue (38%).
    • Transcripts for transforming growth factor alpha and epidermal growth factor receptor were more common in oestrogen receptor-negative carcinomas.
    • Insulin-like growth factor II mRNA was present in all non-malignant tissues but only 52% of carcinomas, often in lower amounts.

    Conclusions:

    • The distinct expression patterns of growth factors in malignant versus non-malignant breast tissue suggest their involvement in breast cancer pathogenesis.
    • Transforming growth factors alpha and beta, in particular, may be critical regulators of human breast cancer growth, especially in hormone-independent cases.
    • Growth factor signaling pathways represent potential therapeutic targets for specific breast cancer subtypes.